Ad-KDRscFv:sTRAIL displays a synergistic antitumor effect without obvious cytotoxicity to normal tissues-Reference-Cited by-同舟云学术

Ad-KDRscFv:sTRAIL displays a synergistic antitumor effect without obvious cytotoxicity to normal tissues

Published:2012-05 Issue:1 Volume:13 Page:37-45
ISSN:1567-5769
Container-title:International Immunopharmacology
language:en
Short-container-title:International Immunopharmacology

Author:

Yang Liuqin,Guo Jun,Wang Jun,Wan Shunmei,Yang Shiming,Wang Rongquan,Chen Wensheng,Peng Guiyong,Fang Dianchun

Funder

Scientific Research Foundation of Chinese PLA

Publisher

Elsevier BV

Subject

Pharmacology,Immunology,Immunology and Allergy

Reference35 articles.

1. Identification and characterization of a new member of the TNF family that induces apoptosis;Wiley;Immunity,1995

2. Differential activation of TRAIL-R1 and −2 by soluble and membrane TRAIL allows selective surface antigen-directed activation of TRAIL-R2 by a soluble TRAIL derivative;Wajant;Oncogene,2001

3. IFNa-stimulated neutrophils and monocytes release a soluble form of TNF-related apoptosis-inducing ligand (TRAIL/Apo-2 ligand) displaying apoptotic activity on leukemic cells;Tecchio;Blood,2004

4. Differential hepatocyte toxicity of recombinant Apo2L/TRAIL versions;Lawrence;Nat Med,2001

5. Adenoviral gene transfer of tumor necrosis factor-related apoptosis-inducing ligand overcomes an impaired response of hepatoma cells but causes severe apoptosis in primary human hepatocytes;Armeanu;Cancer Res,2003

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Apoptosis-Inducing TNF Superfamily Ligands for Cancer Therapy;Cancers;2021-03-27

2. Current Status of Gene Therapy for Hepatocellular Carcinoma, with a Focus on Gene Delivery Approaches;Current Gene Therapy;2015-03-09

3. Targeting Tumor Vasculature Using Adeno-Associated Virus Phage Vectors Coding Tumor Necrosis Factor-α;Gene Therapy of Cancer;2014

4. Sodium nitroprusside (SNP) sensitizes human gastric cancer cells to TRAIL-induced apoptosis;International Immunopharmacology;2013-10